Biomarker Science Advances Drive Shift Towards Predictive Preventive Medicine in Healthcare
Healthcare systems are increasingly focusing on predictive medicine, utilizing advances in imaging, molecular testing, and biomarker science to identify disease risks before symptoms manifest. This shift aims to move clinical and financial value upstream by predicting diseases rather than solely treating them after diagnosis. Chronic conditions currently account for the majority of health expenditures in advanced economies, with most spending occurring post-diagnosis. Preventive medicine, through early detection and screening, seeks to alter this dynamic by delaying disease onset and avoiding associated costs. The commercial market for screening is expanding, attracting private capital into tests, imaging, and monitoring services that were traditionally funded by public health budgets. Key thematic areas driving this evolution include population screening, cancer screening pathways, biomarker validation, advanced imaging with AI-assisted interpretation, at-home sample collection, and occupational health sc... 
